Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1176.00    25.00 (2.17%)
Bid:
1177.00
Ask:
1182.00
Spread: 5.00 (0.425%)
Market Cap: £815.53m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Option exercise and block listing update

31 Jan 2020 17:47

RNS Number : 6508B
CVS Group plc
31 January 2020
 

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Confirmation of Cancellation of Block Listing

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that certain employees have exercised options under the Company's Save As You Earn (SAYE) 2020 scheme (the "SAYE Exercise") totalling 66,249 ordinary shares of 0.2 pence each ("Ordinary Shares") during January.

The SAYE Exercise was satisfied out of the Company's existing Employee Benefit Trust ("EBT") which was first announced on 28 February 2017. As at the date of this announcement, the remaining number of ordinary shares held by the EBT is 72,519.

The Company also announces that its 2015/2018 Save as You Earn option scheme has closed and, as a result, the block listing associated with it has been cancelled. Since the block listing interim review dated 24 June 2019, the Company issued a total of 24,335 shares in satisfaction of the exercise of SAYE options. All such issuance has been previously announced. The Company has no other block listings.

The Company's total issued share capital at the date of this announcement therefore remains unchanged at 70,654,959 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,654,959. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Name of applicant:

CVS Group plc

Name of scheme:

2015/2018 Save as You Earn Scheme

Period of return:

From:

23 June 2019

To:

30 December 2019

Balance of unallotted securities under scheme(s) from previous return:

136,632

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

24,335

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

112,297

Subsequent cancellation:

(112,297)

Equals: Remaining balance under block listing

Nil

 

Contacts:

CVS Group Plc Tel: 01379 644288

Richard Fairman, Chief Executive Officer

David Harris, Company Secretary

 

N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSDMFWFESSELF
Date   Source Headline
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.